![](/img/cover-not-exists.png)
378 Taxol® (paclitaxel) 225 mg/m2 by 3-hour infusion without G-CSF as a second line therapy in patients (PTS) with metastatic breast cancer (MBC)
Ph. Bougnoux, R. Delva, D. Serin, M. Namer, G. Piot, J.P. Lotz, J.F. Ramée, E. Vuillemin, B. Grau, A. Roubinet, J.A. Soares, M. ChazardVolume:
31
Year:
1995
Language:
english
Pages:
1
DOI:
10.1016/0959-8049(95)95631-f
File:
PDF, 170 KB
english, 1995